Metal binding important for metformin action

April 14, 2012
Metal binding important for metformin action
The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action, according to a study published online April 9 in Diabetes.

(HealthDay) -- The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action, according to a study published online April 9 in Diabetes.

Noting that the of metformin is unclear but most evidence has shown that the drug binds to , most stably to copper, rather than protein targets, Lisa Logie, Ph.D., from the University of Dundee in the United Kingdom, and colleagues interfered with the ability of metformin to bind copper and examined the impact on cellular responses.

The researchers found that copper sequestration interfered with the known effects of metformin on AMP-activated (AMPK)-dependent signaling and S6 , which were regulated independently. The metformin-copper interaction was stabilized by extensive pi-electron delocalization, which allowed regulation of AMPK, production of glucose, gluconeogenic gene expression, mitochondrial respiration, and mitochondrial copper binding. In contrast, direct modification of the metal-liganding groups of the biguanide structure prevented regulation of S6 phosphorylation. Further studies showed that pioglitazone also targeted mitochondrial copper.

"In summary, this study indicates that effects of metformin and related compounds on cell responses depend on their ability to interact with copper," Logie and colleagues conclude. "More broadly, our results suggest that the number of targets for drug discovery could be widened not only by investigating nonprotein targets such as copper, but also by considering the role of metal-induced effects on chemical bonding and conformational geometries of drug structures."

Explore further: Diabetes drug can prevent heart disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Diabetes drug can prevent heart disease

March 26, 2012

The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

Recommended for you

Electric fields weaker in slow-healing diabetic wounds

June 16, 2016

People with diabetes often suffer from wounds that are slow to heal and can lead to ulcers, gangrene and amputation. New research from an international group led by Min Zhao, professor of ophthalmology and of dermatology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.